Quibim · Series A
AI-powered imaging biomarkers for precision medicine
Amount
$50M
Round
Series A
Valuation
—
Announced
Jan 2025
Investors
Lead investor
Asabys PartnersParticipating investors
AI-powered imaging biomarkers for precision medicine
Amount
$50M
Round
Series A
Valuation
—
Announced
Jan 2025
Lead investor
Asabys PartnersParticipating investors